surmount-1 trial tirzepatide non-diabetic obesity weight loss lowers body for adults with obesity, regardless of disease duration Tirzepatide as Compared with Semaglutide

Wegovy pens should be clear and colorless

Medicare will cover Wegovy (semaglutide), Foundayo (orforglipron), and the KwikPen formulation of Zepbound (tirzepatide)

This increases the risk of under- or overdosing

Seek immediate medical attention if you experience severe abdominal pain, inability to keep fluids down for more than 24 hours, signs of dehydration, or allergic reactions

Tirzepatide functions as both a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist

Pathological mechanisms disrupt islet organization, hindering cell-to-cell communication, impairing insulin and glucagon release, and exacerbating hyperglycemia [15] Beta cell failure and insulin secretory dysfunction are fundamental in type 2 diabetes, arising from synthesis or secretion process errors